Clinical Trials Logo
  1. Home
  2. Vascular Malformations
  3. NCT05494710

Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study — BEST  

Vascular Malformations Clinical Trial

Official title:
Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study

Clinical Trial Summary

The aim of the BEST study is to examine the feasibility of assessing patient and clinician reported outcome of a single electrosclerotherapy treatment of vascular malformations. - Sclerotherapy = injection of Bleomycin into vascular birthmarks to seal off abnormal vascular channels - Electroporation = application of an electric field to vessels treated with a handheld needle electrode - Electrosclerotherapy = a combination of Bleomycin sclerotherapy and electroporation

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05494710
Study type Interventional
Source South Tees Hospitals NHS Foundation Trust
Contact Clare Proctor
Phone 01642 854192
Email clareproctor1@nhs.net
Status Recruiting
Phase N/A
Start date December 1, 2020
Completion date December 1, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT02561182 - Bone Health in Patients With Overgrowth
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Active, not recruiting NCT03987152 - Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life Phase 3
Recruiting NCT05113420 - The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
Recruiting NCT06189092 - Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
Completed NCT04637997 - Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations N/A
Recruiting NCT02883023 - Electrosclerotherapy for Capillary Malformations Phase 2
Recruiting NCT06160739 - Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations
Completed NCT02991352 - Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study N/A
Recruiting NCT03972592 - Topical Sirolimus in Cutaneous Lymphatic Malformations Phase 2
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Recruiting NCT04104464 - Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
Recruiting NCT02638389 - Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care Phase 3
Recruiting NCT03440827 - Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations N/A
Recruiting NCT05563831 - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Completed NCT00577213 - Diagnosis of Hemangiomas and Vascular Malformations N/A
Enrolling by invitation NCT06399367 - Investigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)
Completed NCT01576601 - The Management of Postoperative Craniotomy Pain in Pediatric Patients N/A
Completed NCT04836884 - Vascular Anomaly Pathology and Genomics Biopsy Study N/A
Not yet recruiting NCT05983159 - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations Phase 2